Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arcturus Therapeutics Holdings Inc. ARCT

Set alert

Price alert · ARCT

All alert types
9.16 USD -0.33 -3.48%

As of Nov 3, 2:30 PM ET

Bid
9.15 × 2
Ask
9.17 × 1
9.13 Day range 10.03
5.50 52-week range 17.96
YTD
+49.43%
1 year
-1.51%
Open
9.55
Prev close
9.49
Mkt cap
260.92M
Vol
527.65K
Avg vol
1.00M
EPS
-3.33
P/E
0.00
Div yield
0.00%
More statistics
Low
9.13
High
10.03
Forward P/E
-7.41
Beta
2.64
Short ratio
9.41
Inst. own
90.16%
Dividend
0.00
Ex-div date
50-d avg
18.22
200-d avg
24.44
1y target
79.47

6M chart

Chart tools
Interval
1m5m15m30m

Signals (29)
NameDateAgo
SMA: BearishNov 2, 20261 day ago
MACD: Sell SignalNov 2, 20261 day ago
MACD: Buy SignalOct 29, 20265 days ago
SMA: BullishOct 27, 20261 week ago
SMA: BearishOct 23, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
MACD: Sell SignalSep 9, 20261 month ago
RSI: OverboughtAug 18, 20262 months ago
RSI: OverboughtAug 14, 20262 months ago
SMA: BullishAug 11, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 7, 20262 months ago
SMA: BullishAug 7, 20262 months ago
MACD: Buy SignalAug 3, 20263 months ago
RSI: OversoldJul 23, 20263 months ago
MACD: Sell SignalJul 14, 20263 months ago
MACD: Buy SignalJul 2, 20264 months ago
MACD: Sell SignalJun 25, 20264 months ago
MACD: Buy SignalJun 17, 20264 months ago
MACD: Sell SignalJun 9, 20264 months ago

Newest 20 of 29.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 79.47 +767.6% upside
Target (low)
44.00
Target (mean)
79.47
Target (high)
140.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy7
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 10
  • 1 month ago 10
  • 2 months ago 10
  • 3 months ago 10

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ARCT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.22333-0.40 – 0.59-0.32+169.8%45.92M+35.1%8
Next quarter-0.2725-0.69 – 0.00-1.00+72.8%53.00M+39.4%4
Current year-1.92-2.30 – -1.290.2765-794.4%175.51M+3.3%8
Next year-1.48-5.15 – 3.12-1.92+22.8%213.90M+21.9%8

Upgrades and downgrades

The latest rating changes

ARCT analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Nov 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2024Leerink PartnersInitiated—Outperform
Aug 8, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 6, 2024Cantor FitzgeraldReiterated—Overweight
Jul 2, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024Canaccord GenuityMaintainedBuyBuy
Mar 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 11, 2024Canaccord GenuityMaintainedBuyBuy
Mar 8, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 8, 2024Wells FargoMaintainedOverweightOverweight
Feb 8, 2024CitigroupMaintainedBuyBuy
Dec 13, 2023Canaccord GenuityInitiated—Buy
Nov 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 27, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 20, 2023HC Wainwright & Co.ReiteratedBuyBuy
Sep 5, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 22, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 24, 2023William BlairInitiated—Outperform
Jul 14, 2023GuggenheimMaintainedBuyBuy
Jul 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 14, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Jun 1, 2023HC Wainwright & Co.Reiterated—Buy
May 11, 2023HC Wainwright & Co.UpgradeNeutralBuy
Mar 29, 2023GuggenheimReiterated—Buy
Mar 29, 2023HC Wainwright & Co.Reiterated—Neutral